Arvinas Inc (ARVN)
32.66
+0.55
(+1.71%)
USD |
NASDAQ |
May 17, 16:00
31.01
-1.65
(-5.05%)
After-Hours: 20:00
Arvinas Market Cap: 2.236B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.236B |
| May 16, 2024 | 2.197B |
| May 15, 2024 | 2.212B |
| May 14, 2024 | 2.146B |
| May 13, 2024 | 2.160B |
| May 10, 2024 | 2.151B |
| May 09, 2024 | 2.186B |
| May 08, 2024 | 2.215B |
| May 07, 2024 | 2.349B |
| May 06, 2024 | 2.208B |
| May 03, 2024 | 2.246B |
| May 02, 2024 | 2.215B |
| May 01, 2024 | 2.219B |
| April 30, 2024 | 2.170B |
| April 29, 2024 | 2.179B |
| April 26, 2024 | 2.211B |
| April 25, 2024 | 2.159B |
| April 24, 2024 | 2.223B |
| April 23, 2024 | 2.322B |
| April 22, 2024 | 2.384B |
| April 19, 2024 | 2.372B |
| April 18, 2024 | 2.342B |
| April 17, 2024 | 2.285B |
| April 16, 2024 | 2.284B |
| April 15, 2024 | 2.372B |
| Date | Value |
|---|---|
| April 12, 2024 | 2.479B |
| April 11, 2024 | 2.545B |
| April 10, 2024 | 2.509B |
| April 09, 2024 | 2.601B |
| April 08, 2024 | 2.572B |
| April 05, 2024 | 2.557B |
| April 04, 2024 | 2.589B |
| April 03, 2024 | 2.636B |
| April 02, 2024 | 2.667B |
| April 01, 2024 | 2.760B |
| March 28, 2024 | 2.811B |
| March 27, 2024 | 2.814B |
| March 26, 2024 | 2.791B |
| March 25, 2024 | 2.769B |
| March 22, 2024 | 2.853B |
| March 21, 2024 | 2.951B |
| March 20, 2024 | 3.007B |
| March 19, 2024 | 2.898B |
| March 18, 2024 | 2.900B |
| March 15, 2024 | 3.054B |
| March 14, 2024 | 3.045B |
| March 13, 2024 | 3.165B |
| March 12, 2024 | 3.096B |
| March 11, 2024 | 3.098B |
| March 08, 2024 | 3.203B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
509.05M
Minimum
Oct 18 2019
5.298B
Maximum
Jul 29 2021
2.261B
Average
2.001B
Median
Dec 13 2022
Market Cap Benchmarks
| Pfizer Inc | 162.29B |
| Johnson & Johnson | 372.17B |
| Bristol-Myers Squibb Co | 89.25B |
| Janux Therapeutics Inc | 2.442B |
| ACADIA Pharmaceuticals Inc | 2.444B |
Market Cap Related Metrics
| PS Ratio | 27.55 |
| PEG Ratio | -1.155 |
| Price to Book Value | 3.668 |
| Price | 32.66 |
| Earnings Yield | -18.15% |
| PEGY Ratio | -1.155 |